Cargando…
Denosumab-Induced Severe Hypocalcaemia in Chronic Kidney Disease
BACKGROUND: Hypocalcaemia is increasingly recognized as a complication of denosumab use in Chronic Kidney Disease (CKD) patients with osteoporosis. Despite Therapeutic Goods Administration (TGA) notifications in 2013, we have subsequently encountered several cases of denosumab-induced hypocalcaemia,...
Autores principales: | Jalleh, Ryan, Basu, Gopal, Le Leu, Richard, Jesudason, Shilpanjali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6241374/ https://www.ncbi.nlm.nih.gov/pubmed/30519493 http://dx.doi.org/10.1155/2018/7384763 |
Ejemplares similares
-
Refractory Shock Secondary to Denosumab-induced Severe Hypocalcaemia
por: Eshak, Nouran, et al.
Publicado: (2022) -
Severe hypocalcaemia following denosumab and iron infusion
por: Cohen, Adrienne, et al.
Publicado: (2022) -
Denosumab-induced hypocalcaemia in metastatic castrate-resistant prostate cancer
por: Gunawan, Florence, et al.
Publicado: (2019) -
Dramatic increase in parathyroid hormone and hypocalcaemia after denosumab in a kidney transplanted patient
por: Torregrosa, Jose-Vicente
Publicado: (2013) -
OA11 Osteoporosis, denosumab, and hypocalcaemia in multimorbid renal impairment
por: Daurat, Jean-Luc, et al.
Publicado: (2023)